DOCSLIB.ORG

Standard-Hospital-Charges-P.-1.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Standard-Hospital-Charges-P.-1.Pdf Item Number Item Description Charge Amount 232612 NF-ENSURE BONE HEALTH CALTRIUS ORAL LIQU $1.00 232857 NF-FERROUS SULFATE ELIX 220MG/5ML $1.00 232946 NF-VITAMIN B COMPLEX TABLET $1.00 233014 NF-IRON TABLET 65MG $1.00 233024 NF-ASPIRIN EC 81MG ORAL TABLET, ENTERIC $1.00 233240 NF-CAFFEINE TABLET 200MG $1.00 233541 NF-OASIS MOISTURIZING MOUTHWASH MM SOLUT $1.00 233759 NF-ASPIRIN CHEWABLE TABLET 81MG $1.00 233956 NF-BIOTENE DRY MOUTH MOUTHWASH MM SOLUTI $1.00 234343 NF-ENSURE PLUS LIQUID $1.00 234344 NF-ENSURE PLUS LIQUID $1.00 234828 NF-IRON TABLET 65MG $1.00 234874 NF-ALOE VESTA SKIN CONDITIONER LOTION 3% $1.00 234904 NF-GENTLE SENSITIVE EYES PLUS SALINE SOL $1.00 234990 NF-GERITOL LIQUID $1.00 235220 NF-HIBICLENS LIQUID 4% $1.00 235824 NF-ALOE VERA CREAM $1.00 235877 NF-THIAMINE HCL TABLET 50MG $1.00 236130 NF-CALCIUM ANTACID CHEWABLE TAB 500MG $1.00 236348 NF-ASPIRIN ADULT LOW DOSE ORAL TAB EC 81 $1.00 236389 NF-PSYLLIUM HUSK PWD FOR SUSP 3.4GM/1DOS $1.00 236430 NF-PSYLLIUM HUSK PWD FOR SUSP 3.4GM/1DOS $1.00 236844 NF-THIAMINE HCL TABLET 50MG $1.00 236897 NF-THIAMINE HCL TABLET 50MG $1.00 236996 NF-THIAMINE HCL TABLET 50MG $1.00 237268 NF-LIDOCAINE HCL INJECTION 2% $1.00 237554 NF-PETROLATUM HYDRATED OINTMENT $1.00 238420 NF-BETADINE SURGICAL SCRUB SOLUTION 7.5% $1.00 238673 NF-PETROLATUM WHITE OINTMENT $1.00 239545 NF-FOLIC ACID ORAL TABLET 0.4MG $1.00 239576 NF-DEXTROSE AND SOD CL IV SOLN 5%-0.45% $1.00 239763 NF-IRON ORAL TABLET 325MG $1.00 239847 NF-BIOTENE PBF DRY MOUTH MOUTHWASH MM SO $1.00 240051 NF-IRON TABLET 65MG $1.00 240058 NF-MYLANTA SUSPENSION $1.00 240191 NF-CHLORHEXIDINE GLUCONATE LIQ 0.12% $1.00 240205 NF-CALAMINE LOTION TOPICAL SUSPENSION 8% $1.00 240651 NF-IRON TABLET 65MG $1.00 241312 NF-CHLORHEXIDINE GLUCONATE LIQ 0.12% $1.00 241347 NF-ZINC OXIDE OINTMENT 20% $1.00 241622 NF-CETAPHIL LOTION $1.00 241623 NF-CALAMINE LOTION $1.00 241990 NF-FOLIC ACID ORAL TABLET 0.8MG $1.00 241994 NF-MULTIVITAMIN TAB NO STRENGTH $1.00 241995 NF-MULTIVITAMIN TAB NO STRENGTH $1.00 242023 NF-FOLIC ACID ORAL TABLET 0.8MG $1.00 242125 NF-TRIAMCINOLONE ACETONIDE OINTMENT 0.1% $1.00 242337 NF-JEVITY 1.5 CAL SUSPENSION $1.00 242412 NF-JEVITY 1.5 CAL ORAL SOLUTION $1.00 232329 NF-GUAIFENESIN SYRUP 100MG/5ML $1.00 232364 NF-GAVISCON ESRF SUSPENSION $1.00 232505 NF-CALCIUM/VITAMIN D TABLET $1.00 232654 NF-CALCIUM CARBONATE-ERGOCALCIFEROL TAB $1.00 232668 NF-CALCIUM CARBONATE CHEW TAB 500MG $1.00 232727 NF-DIPHENHIST LIQUID 12.5MG/5ML $1.00 232806 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 232879 NF-CALAMINE LOTION $1.00 232917 NF-IRON TABLET 324MG $1.00 232994 NF-ACIDOPHILUS CAPSULE $1.00 233023 NF-CALCIUM 500 W/VITAMIN D TABLET $1.00 233040 NF-CALCIUM 500 + D ORAL TABLET 400IU-500 $1.00 233164 NF-DAILY MULTIPLE VITAMINS TABLET $1.00 233189 NF-VITAMIN D2 400IU ORAL TABLET $1.00 233281 NF-HIBICLENS TOPICAL SOLUTION 4Ð $1.00 233615 NF-AVEENO ACTIVE NATURALS ECZEMA THERAPY $1.00 233616 NF-AVEENO BABY DAILY MOISTURE LOTION $1.00 233814 NF-ASPIRIN FOR CHILDREN 81MG ORAL TABLET $1.00 233853 NF-POTASSIUM GLUCONATE TABLET 595MG $1.00 234114 NF-VITAMIN D NATURAL TABLET 400IU $1.00 234223 NF-CALAMINE LOTION $1.00 234606 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 234609 NF-ASPIRIN EC 81MG ORAL TABLET, ENTERIC $1.00 234686 NF-ALKA-MINTS CHEWABLE TAB 850MG $1.00 234784 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 234791 NF-CHLORHEXIDINE GLUCONATE LIQ 0.12% $1.00 234840 NF-ASPIR 81 81MG ORAL TABLET, ENTERIC CO $1.00 234853 NF-VITAMIN A CAPSULE 10,000IU $1.00 235094 NF-VITAMIN A CAPSULE 10,000IU $1.00 235193 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 235277 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 235363 NF-FEROSUL TAB 325MG $1.00 235543 NF-CENTAMIN LIQUID $1.00 235561 NF-CALCIUM 600MG+D ORAL TABLET 600MG-200 $1.00 235638 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 235682 NF-AVEENO CLEAR COMPLEXION CLEANSING BAR $1.00 235839 NF-DIPHENHYDRAMINE ELIX 12.5MG/5ML $1.00 236020 NF-CALCIUM WITH VITAMIN D3 TAB 400IU-600 $1.00 236109 NF-DML LOTION $1.00 236196 NF-ACETAMINOPHEN CAP 500MG $1.00 236310 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 236311 NF-VITAMIN B-12 ORAL TABLET 100MCG $1.00 236350 NF-ASPIRIN FOR CHILDREN CHEW TAB 81MG $1.00 236409 NF-FERROUS SULFATE ORAL TABLET 65MG $1.00 236432 NF-MELATONIN TABLET 0.3MG $1.00 236478 NF-VITAMIN A CAPSULE 8000IU $1.00 236524 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 236642 NF-CALAMINE LOTION $1.00 236652 NF-DML LOTION $1.00 236661 NF-FOLIC ACID ORAL TABLET 0.8MG $1.00 236688 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 236707 NF-ACIDOPHILUS CAPSULE $1.00 236866 NF-TOLNAFTATE SPRAY 1Ð $1.00 236968 NF-AVEENO BATH TREATMENT PWD FOR SUSP 10 $1.00 237153 NF-IRON ADVANCED TABLET $1.00 237187 NF-B COMPLEX TABLET $1.00 237196 NF-AVEENO DAILY MOISTURIZING LOTION 1.25 $1.00 237239 NF-POTASSIUM GLUCONATE TABLET 550MG $1.00 237305 NF-VITAMIN D3 TABLET 1000IU $1.00 237372 NF-COD LIVER OIL CAPSULE $1.00 237432 NF-AVEENO ACTIVE NATURAL NOURISH+MOISTUR $1.00 237468 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 237498 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 237669 NF-VITAMIN B-1 50MG ORAL TABLET $1.00 237847 NF-HYDROCORTISONE CREAM 2.5% $1.00 237960 NF-CHLORHEXIDINE GLUCONATE LIQ 0.12% $1.00 238126 NF-METAMUCIL FIBER 3.4GM/1DOSE $1.00 238254 NF-CETAPHIL DAILY FACIAL CLEANSER LIQUID $1.00 238331 NF-CETAPHIL DAILY FACIAL CLEANSER LIQUID $1.00 238551 NF-FERROUS SULFATE ORAL TABLET 65MG $1.00 238646 ACETAMINOPHEN EXTRA STRENGTH TAB 500MG $1.00 238770 NF-FERROUS SULFATE ORAL TABLET 65MG $1.00 238776 NF-ZINC OXIDE OINTMENT $1.00 238927 NF-SORE THROAT SPRAY 1.4% $1.00 239190 NF-ACETAMINOPHEN CAP 500MG $1.00 239401 NF-CETAPHIL DAILY FACIAL CLEANSER LIQUID $1.00 239677 NF-ACETAMINOPHEN CAP 500MG $1.00 239771 NF-HYDROCORTISONE CREAM 2.5% $1.00 240006 NF-VITAMIN B-12 ORAL TABLET 100MCG $1.00 240123 NF-ACETAMINOPHEN CAP 500MG $1.00 240212 NF-SALINE NASAL SPRAY 0.65% $1.00 240217 NF-PREVIDENT DENTAL RINSE SOLUTION 0.2% $1.00 240625 NF-CETAPHIL DAILY FACIAL CLEANSER LIQUID $1.00 240969 NF-CALCIUM MAGNESIUM ZINC W/VITAMIN D TA $1.00 240977 NF-FOLIC ACID ORAL TABLET 800MCG $1.00 241293 NF-ACETAMINOPHEN EXTRA STRENGT TABLET 50 $1.00 241443 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 241447 NF-MELATONIN TABLET 1MG $1.00 241511 NF-LYSINE 500 TABLET 500MG $1.00 241866 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 241888 NF-VITAMIN B-12 ORAL TABLET 100MCG $1.00 242029 NF-VOLUMEN SUSP 0.1% $1.00 242062 NF-FOLIC ACID ORAL TABLET 800MCG $1.00 242063 NF-VOLUMEN SUSP 0.1% $1.00 242297 NF-LUBRIDERM DAILY MOISTURE TOPICAL LOTI $1.00 242715 NF-STOOL SOFTENER W/LAXATIVE TAB 50MG-8. $1.00 242798 NF-ACETAMINOPHEN CAP 500MG $1.00 242843 NF-CALAMINE PHENOLATED LOTION 8%-1% $1.00 242882 NF-MAGNESIUM OXIDE TABLET 250MG $1.00 124205 COTTON BALL $1.00 232282 NF-POTASSIUM GLUCONATE NATURAL TABLET 55 $1.00 232361 NF-GOLD BOND MEDICATED BODY POWDER $1.00 232805 NF-VITAMIN D3 TAB 1,000IU $1.00 232882 NF-CETAPHIL MOISTURIZER CREAM $1.00 232897 NF-FISH OIL ORAL LIQUID CAPSULE 1000MG $1.00 232933 NF-VITAMIN A & D TOPICAL OINTMENT $1.00 232993 NF-ACIDOPHILUS CAPSULE $1.00 233052 NF-THIAMINE HCL 100MG ORAL TABLET $1.00 233132 NF-COD LIVER OIL CAPSULE $1.00 233159 NF-SALINE SOLUTION 0.9% $1.00 233211 NF-CALCIUM + D ORAL TABLET 500MG-125IU $1.00 233648 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 233741 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 233815 NF-VICKS 44 COUGH RELIEF LIQUID 10MG/5ML $1.00 233848 NF-STANNOUS FLUORIDE SOLN 0.63% $1.00 233864 NF-VITAMIN D ORAL TABLET 1000IU $1.00 233884 NF-VITAMIN A PALMITATE TABLET 10,000IU $1.00 233929 NF-AQUA CARE LOTION 10% $1.00 234018 NF-B-COMPLEX W/VITAMIN C CAPSULE $1.00 234260 NF-VITAMIN D3 TAB 1,000IU $1.00 234261 NF-VITAMIN D3 TAB 1,000IU $1.00 234338 NF-ZINC CHELATED TABLET 50MG $1.00 234362 NF-HIBICLENS LIQUID 4% $1.00 234565 NF-POTASSIUM GLUCONATE TABLET 595MG $1.00 234568 NF-POTASSIUM GLUCONATE TABLET 595MG $1.00 234578 NF-CHLORHEXIDINE GLUCONATE LIQ 0.12% $1.00 234745 NF-CHLORHEXIDINE GLUCONATE LIQ 0.12% $1.00 234757 NF-VITAMIN D3 TAB 1,000IU $1.00 235174 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 235272 NF-VITAMIN D3 TABLET 1000IU $1.00 235403 NF-BACTINE LIQUID $1.00 235410 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 235459 NF-TUMS CHEWABLE TAB 500MG $1.00 235533 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 235640 NF-VITAMIN B1 TABLET 50MG $1.00 235643 NF-METAMUCIL MULTIHEALTH FIBER 3.3GM/1DO $1.00 235680 NF-VITAMIN D3 TABLET 1000IU $1.00 235751 NF-METAMUCIL CLEAR AND NATURAL ORAL POWD $1.00 235820 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 236023 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 236025 NF-B-12 TABLET 500MCG $1.00 236098 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 236128 NF-VITAMIN D3 TABLET 1000IU $1.00 236188 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 236200 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 236203 NF-VITAMIN D3 TAB 1,000IU $1.00 236317 NF-DOC-Q-LACE ORAL LIQ CAP 100MG $1.00 236410 NF-DOC-Q-LACE ORAL LIQ CAP 100MG $1.00 236548 NF-EYE IRRIGATING SOLUTION OPHTH SOLUTIO $1.00 236598 NF-VITAMIN D ORAL TABLET 2000IU $1.00 236609 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 236757 NF-CALCIUM/MAGNESIUM CHELATED ZINC TABLE $1.00 236823 NF-GOLD BOND MEDICATED BABY POWDER $1.00 236912 NF-OPTI-FREE REPLENISH OPHTHALMIC SOLUTI $1.00 237054 NF-ASPIRIN ADULT LOW STRENGTH TABLET 81M $1.00 237094 NF-VITAMIN D3 ORAL TABLET 1000IU $1.00 237170 NF-OCEAN SALINE NASAL SPRAY 0.65% $1.00 237241 NF-POTASSIUM GLUCONATE TABLET 550MG $1.00 237313 NF-IRON TABLET 65MG $1.00 237467 NF-GLYCERIN RECTAL SUPP $1.00 237505 NF-SAF-CLENS AF IRRIGATION SOLUTION $1.00 237764 NF-VITAMIN B1 100MG ORAL TABLET $1.00 237795 NF-IMODIUM A-D ORAL SOLUTION 1MG/7.5ML $1.00 237873 NF-MET-RX TOTAL NUTRITION DRINK POWDER $1.00 237932 NF-VITAMIN D3 ORAL TABLET
Load more

Recommended publications
  • Sodium Gluconate and Potassium Gluconate As Substitutes for Sodium Chloride in Breadmaking
    Food Sci. Technol. Res., 8 (1), 75–79, 2002 Sodium Gluconate and Potassium Gluconate as Substitutes for Sodium Chloride in Breadmaking Hiroyuki TAKANO1 and Ryouko KONDOU2 1National Food Research Institute, Tsukuba Science City, Ibaraki, 305-8642, Japan 2Fujisawa Pharmaceutical Co., LTD., 5-2-3 Tokodai, Tsukuba, Ibaraki, 300-2698, Japan Received September 5, 2001; Accepted November 30, 2001 Sodium gluconate (Na-gluconate) and potassium gluconate (K-gluconate) were used as NaCl substitutes in bread- making to determine their potential usefulness in preparing reduced-sodium bread and non-sodium bread. Replace- ment of 75% of the NaCl by Na-gluconate and of 50% by K-gluconate had no effect on rheological properties of dough as measured by Brabender Extensograph. Replacement of 100% of the NaCl by either Na-gluconate or K-glu- conate resulted in decreased resistance to extension, but the decreased resistance to extension had no effect on dough handling properties. Expansion of white bread dough (5% sugar, flour weight basis) increased with the proportion of NaCl replaced by Na-gluconate or K-gluconate. The patterns of carbon dioxide production during fermentation of non-sugar bread dough showed that as the proportion of Na-gluconate or K-gluconate increased, the time required to complete fermentation decreased, and the fermentation pattern showed a gradual resemblance to that seen in non- sugar bread dough without NaCl. In white bread, complete replacement of NaCl (2%, flour weight basis) by Na-glu- conate or K-gluconate did not cause a difference in loaf volume, nor did it have any significant effect on overall desir- ability.
    [Show full text]
  • Potassium Gluconate
    POTASSIUM GLUCONATE Cambridge Commodities Chemwatch Hazard Alert Code: 2 Chemwatch: 48667 Issue Date: 27/06/2017 Version No: 5.1.23.11 Print Date: 27/09/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 S.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name POTASSIUM GLUCONATE Chemical Name potassium gluconate CH2OH.[CH(OH)]4.CO2K; gluconic acid, potassium salt, D-; D-gluconic acid, monopotassium salt; gluconic acid, potassium salt; Synonyms potassium D-gluconate; Gluconsan K Kalium-Beta Kaon Elixir Katorin K-IAO Potalium; Potasoral Potassuril Sirokal Chemical formula C6H12O7.K Other means of P16164 identification CAS number 299-27-4 EC number 206-074-2 REACH registration 01-2119455845-28-XXXX number 1.2. Relevant identified uses of the substance or mixture and uses advised against Because potassium gluconate is almost tasteless it is a convenient for the prevent and treatment of potassium deficiency by oral Relevant identified uses administration. Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name Cambridge Commodities Address Lancaster Way Business Park, Ely, Cambridgeshire Cambridgeshire CB6 3NX United Kingdom Telephone +44 1353 667258 Fax Not Available Website Not Available Email [email protected] 1.4. Emergency telephone number Association / Organisation Not Available Product code: Version No: 5.1.23.2 Page 1 of 20 S.REACH.GB.EN Lancaster Way Business Park Safety Data Sheet (Conforms to Regulation (EU) No 2020/878) Ely, Cambridgeshire, CB6 3NX, UK.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • Intracellular Solution
    Recipes for Physiological Recording Sucrose slicing solution Regents MM MW Gram/L Gram/4L KCl 2.5 74.56 0.186 0.746 NaH2PO4 1.25 137.99 0.173 0.692 MgCl2 7 203.3 7ml stock 28ml stock CaCl2 0.5 147.02 0.5ml stock 2ml stock NaHCO3 25 81.01 2.1 8.4 Glucose 11 198.17 2.18 8.72 Sucrose 234 342.3 80.1 320.4 K-gluconate intracellular solution Regents Concentration Molecular To make To make (mM) weight 100ml (mg) 20ml (mg) KCl 20 74.56 149 K-gluconate 120 234.56 2810 MgCl2 2 203.3 40 EGTA 0.2 380.4 7.6 HEPES 10 238.3 238.3 *Na2-ATP 2 551.1 112.2 pH 7.3 mit KOH, ~305mOsm Potassium Intracellular solution for 100ml 1. Potassium Gluconate 120mM 2,810.5mg 2. Potassium Chloride 20 150 3. GTP 0.3 4. EGTA 0.2 (or 0.02) 0.8 (0.08) 5. HEPES 10 24 6. Buffer pH to 7.25 with KOH, and filtered with 0.2μm filter, then add ATP 7. ATP-Mg 4 200 8. Aliquot by 1.5ml Cesium Intracellular solution for 100ml (243mM, modified from Weliky and Katz, J. Neurosci. 1994, 14:7291-7305) @ Regents Concentration Molecular To make To make (mM) weight 100ml (mg) 20ml (mg) D-gluconic acid (free acid, 45- 110 196.2 3.5ml 0.7ml 50% w/w) solution CsOH 110 167.9 1,847 369.4 CsCl2 10 168.4 168.4 33.7 EGTA 1 380.4 38 7.6 CaCl2 1 147.02 14.7 2.94 HEPES 10 238.3 238.3 47.7 *ATP-Mg 1 507.2 51 10.14 *Filtered with 0.2um filter before adding ATP-Mg.
    [Show full text]
  • List of Annexures Annexure – I Plant Layout Annexure – II Manufacturing Process Annexure – III Details of Storage of So
    List of Annexures Annexure – I Plant Layout Annexure – II Manufacturing Process Annexure – III Details of Storage of Solvents Annexure – IV Water Balance & Details of Treatment and disposal of Effluent Annexure – V Details of Treatment and Disposal of Solid Waste Annexure – VI List of Raw materials & Quantity of Consumption Annexure – VII Point Source Emissions – Stack Emission Characteristics Annexure – VIII Details of Fugitive Emissions Annexure – IX Risk Identification Annexure – X Topo Map & Administrative Set-up Map Annexures 1 GCPL ANNEXURE – I PLANT LAYOUT Annexures 2 GCPL Annexures 3 GCPL Annexures 4 GCPL ANNEXURE – II MANUFACTURING PROCESS Annexures 5 GCPL Manufacturing Process Existin g Calcium Gluconate Gluconic Acid procured from market is neutralized with Calcium carbonate, filtered, crystallised, centrifuged, dried, milled and packed. NEUTRALISATION FILTERATION CRYSTALLISATION PACKING MILLING DRYING CENTRIFUGING Alternate process for the manufacture of Calcium Gluconate Gluconic acid is neutralised with Calcium carbonate, filtered, crystallised, centrifuged, dried, milled and packed. NEUTRALISATION FILTRATION CRYSTALLISATION PACKING MILLING DRYING CENTRIFUGING Alternate process GLUCONO DELTA LACTONE + CaCO + WATER 3 FILTRATION CRYSTALLISATION (NEUTRALISATION) PACKING MILLING DRYING CENTRIFUGING Annexures 6 GCPL Sodium Gluconate Gluconic acid brought from the market is neutralised with Sodium bi-carbonate, filtered, concentrated, crystallised, centrifuged, dried, milled and packed. CONCENTRATION NEUTRALISATION FILTRATION CRYSTALLISATION
    [Show full text]
  • Oral Care Compositions Which Comprise Stannous, Potassium and Monoflurophosphate
    (19) & (11) EP 2 281 544 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 09.02.2011 Bulletin 2011/06 A61K 8/19 (2006.01) A61K 8/21 (2006.01) A61Q 11/00 (2006.01) (21) Application number: 09166511.7 (22) Date of filing: 27.07.2009 (84) Designated Contracting States: (72) Inventor: Strand, Ross AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Bracknell, Berkshire RG42 3RZ (GB) HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR (74) Representative: Clemo, Nicholas Graham Designated Extension States: Procter & Gamble Technical Centres Limited AL BA RS Patent Department Rusham Park (71) Applicant: The Procter and Gamble Company Whitehall Lane Cincinnati, OH 45202 (US) Egham Surrey TW20 9NW (GB) (54) Oral care compositions which comprise stannous, potassium and monoflurophosphate (57) The present invention relates to a single phase The composition of the invention has been found to oral care composition comprising: allow prolonged contact between stannous ion and ni- a. a stannous salt trate ion in a single dentifrice without toxic effects or in- b. a potassium salt soluble products. The invention further provides for the c. a chelant maintenance of an efficacious fluoride ion level. d. monofluorophosphate (MFP). EP 2 281 544 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 281 544 A1 Description FIELD OF THE INVENTION 5 [0001] The present invention relates to oral care compositions comprising both tin (II) and potassium ions as well as monofluorophosphate (MFP).
    [Show full text]
  • Short-Term RCT of Increased Dietary Potassium from Potato Or
    nutrients Article Short-Term RCT of Increased Dietary Potassium from Potato or Potassium Gluconate: Effect on Blood Pressure, Microcirculation, and Potassium and Sodium Retention in Pre-Hypertensive-to-Hypertensive Adults Michael S. Stone, Berdine R. Martin and Connie M. Weaver * Nutrition Science, Purdue University, West Lafayette, IN 47907, USA; [email protected] (M.S.S.); [email protected] (B.R.M.) * Correspondence: [email protected] Abstract: Increased potassium intake has been linked to improvements in cardiovascular and other health outcomes. We assessed increasing potassium intake through food or supplements as part of a controlled diet on blood pressure (BP), microcirculation (endothelial function), and potassium and sodium retention in thirty pre-hypertensive-to-hypertensive men and women. Participants were randomly assigned to a sequence of four 17 day dietary potassium treatments: a basal diet (control) of 60 mmol/d and three phases of 85 mmol/d added as potatoes, French fries, or a potassium gluconate supplement. Blood pressure was measured by manual auscultation, cutaneous microvascular and endothelial function by thermal hyperemia, utilizing laser Doppler flowmetry, and mineral retention by metabolic balance. There were no significant differences among treatments for end-of-treatment Citation: Stone, M.S.; Martin, B.R.; BP, change in BP over time, or endothelial function using a mixed-model ANOVA. However, there Weaver, C.M. Short-Term RCT of was a greater change in systolic blood pressure (SBP) over time by feeding baked/boiled potatoes Increased Dietary Potassium from compared with control (−6.0 mmHg vs. −2.6 mmHg; p = 0.011) using contrast analysis. Potassium Potato or Potassium Gluconate: Effect retention was highest with supplements.
    [Show full text]
  • Submission for Potassium
    MCC submission – Potassium Submission for Potassium Part A 1. International Non-proprietary Name (or British Approved Name or US Adopted Name) of the medicine. Potassium. 2. Proprietary name(s). Not applicable. 3. Name of the company / organisation / individual requesting a reclassification. Not applicable. This request is made on behalf of the natural health products industry. 4. Dose form(s) and strength(s) for which a change is sought. Not applicable. This request is made on behalf of the natural health products industry. 5. Pack size and other qualifications. Not applicable. This request is made on behalf of the natural health products industry. 6. Indications for which change is sought. Not applicable. This request is made on behalf of the natural health products industry. 7. Present classification of the medicine. At the present time, potassium is: • Unscheduled when in products for external use. • Unscheduled when in products for oral use, containing 100 mg or less. • Unscheduled in medicines for oral rehydration therapy parenteral nutrition replacement or dialysis. • Unscheduled in glucosamine sulphate complexed products containing 600 mg or less of potassium chloride per recommended dose. • Pharmacy-only medicine when in slow-release or enteric coated forms for internal use. • Pharmacy-only medicine when in medicines containing more than 100 mg per recommended dose (except in the situations described above when potassium is unscheduled) Other potassium compounds that are specifically named in the Medicines schedule that are potentially affected are: Potassium bromide Prescription medicine Page 1 of 9 MCC submission – Potassium Potassium chlorate Unscheduled when in medicines containing 10% or less, and Pharmacy-only medicine when in medicines containing more than 10% Potassium perchlorate Prescription medicine The request to increase the allowed dose of potassium does not involve the scheduling of these other specifically-named potassium substances.
    [Show full text]
  • “Inert” Ingredients Used in Organic Production
    “Inert” Ingredients Used in Organic Production Terry Shistar, PhD A Beyond Pesticides Report he relatively few registered pesticides allowed in organic production are contained in product formulations with so-called “inert” ingredients that are not disclosed on the T product label. The “inerts” make up the powder, liquid, granule, or spreader/sticking agents in pesticide formulations. The “inerts” are typically included in products with natural or synthetic active pesticide ingredients recommended by the National Organic Standards Board (NOSB) and listed by the National Organic Program (NOP) on the National List of Allowed and Prohibited Substances. Any of the pesticides that meet the standards of public health and environmental protection and organic compatibility in the Organic Foods Production Act (OFPA) may contain “inert” ingredients. Because the standards of OFPA are different from those used by the U.S. Environmental Protection Agency (EPA) to regulate pesticides and given changes in how the agency categorizes inerts, the NOSB has adopted a series of recommendations since 2010 that established a substance review process as part of the sunset review. NOP has not followed through on the Board’s recommendations and, as a result, there are numerous materials in use that have not been subject to OFPA criteria. This report (i) traces the history of the legal requirements for review by the NOSB, (ii) identifies the universe of toxic and nontoxic materials that make of the category of “inerts” used in products permitted in organic production, and (iii) suggests a path forward to ensure NOSB compliance with OFPA and uphold the integrity of the USDA organic label.
    [Show full text]
  • Possible Prospects for Using Modern Magnesium Preparations for Increasing Stress Resistance During COVID-19 Pandemic
    Research Results in Pharmacology 6(4): 65–76 UDC: 615.331 DOI 10.3897/rrpharmacology.6.59407 Review Article Possible prospects for using modern magnesium preparations for increasing stress resistance during COVID-19 pandemic Maria V. Sankova1, Olesya V. Kytko1, Renata D. Meylanova1, Yuriy L. Vasil’ev1, Michael V. Nelipa1 1 I.M. Sechenov First Moscow State Medical University (Sechenov University), N.V. Sklifosofsky Institute of Clinical Medicine, 8-2 Trubetskaya St. Moscow 119991, Russian Federation Corresponding author: Olesya V. Kytko ([email protected]) Academic editor: Tatyana Pokrovskaia ♦ Received 7 October 2020 ♦ Accepted 7 December 2020 ♦ Published 29 December 2020 Citation: Sankova MV, Kytko OV, Meylanova RD, Vasil’ev YuL, Nelipa MV (2020) Possible prospects for using modern magnesium preparations for increasing stress resistance during COVID-19 pandemic. Research Results in Pharmacology 6(4): 65–76. https://doi. org/10.3897/rrpharmacology.6.59407 Abstract Introduction: The relevance of the issue of increasing stress resistance is due to a significant deterioration in the mental health of the population caused by the special conditions of the disease control and prevention during the COVID-19 pandemic. Recently, the decisive role in the severity of clinico-physiological manifestations of maladjustment to stress is assigned to magnesium ions. The aim of the work was to study the magnesium importance in the body coping mechanisms under stress for the pathogenetic substantiation of the magnesium correction in an unfavorable situation of disease control and prevention during the COVID-19 pandemic. Materials and methods: The theoretical basis of this scientific and analytical review was an analysis of modern Russian and foreign literature data posted on the electronic portals MEDLINE, PubMed-NCBI, Scientific Electronic Library eLIBRARY.RU, Google Academy, and CyberLeninka.
    [Show full text]
  • FCC 10, Second Supplement the Following Index Is for Convenience and Informational Use Only and Shall Not Be Used for Interpretive Purposes
    Index to FCC 10, Second Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to effective articles, this Index may also include items recently omitted from the FCC in the indicated Book or Supplement. The monographs and general tests and assay listed in this Index may reference other general test and assay specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire FCC publication. For the most current version of the FCC please see the FCC Online. Second Supplement, FCC 10 Index / Allura Red AC / I-1 Index Titles of monographs are shown in the boldface type. A 2-Acetylpyrrole, 21 Alcohol, 90%, 1625 2-Acetyl Thiazole, 18 Alcohol, Absolute, 1624 Abbreviations, 7, 3779, 3827 Acetyl Valeryl, 608 Alcohol, Aldehyde-Free, 1625 Absolute Alcohol (Reagent), 5, 3777, Acetyl Value, 1510 Alcohol C-6, 626 3825 Achilleic Acid, 25 Alcohol C-8, 933 Acacia, 602 Acid (Reagent), 5, 3777, 3825 Alcohol C-9, 922 ªAccuracyº, Defined, 1641 Acid-Hydrolyzed Milk Protein, 22 Alcohol C-10, 390 Acesulfame K, 9 Acid-Hydrolyzed Proteins, 22 Alcohol C-11, 1328 Acesulfame Potassium, 9 Acid Calcium Phosphate, 240 Alcohol C-12, 738 Acetal, 10 Acid Hydrolysates of Proteins, 22 Alcohol C-16, 614 Acetaldehyde, 11 Acidic Sodium Aluminum Phosphate, Alcohol Content of Ethyl Oxyhydrate Acetaldehyde Diethyl Acetal, 10 1148 Flavor Chemicals (Other than Acetaldehyde Test Paper, 1636 Acidified Sodium Chlorite
    [Show full text]
  • Food Supplements: Permitted Vitamins and Minerals
    Food Supplements List of Vitamins and Minerals which may be used in the manufacture of food supplements in the EU Digital ISBN 978 0 7504 7646 1 © Crown copyright 2012 WG15822 Important note This document was correct at the time of publishing. The lists of vitamins and minerals permitted for use in food supplements is subject to change. Please ensure you check the European Commission’s website for any amendments to the list (Click here) Vitamins and minerals which may be used in the manufacture of food supplements as permitted by Directive 2002/46/EC relating to food supplements1 Vitamins Unit of Minerals Unit of measurement measurement Vitamin A μg RE Calcium mg Vitamin D μg Magnesium mg Vitamin E mg α-TE Iron mg Vitamin K μg Copper μg Vitamin B1 mg Iodine μg Vitamin B2 mg Zinc mg Niacin mg NE Manganese mg Pantothenic acid mg Sodium mg Vitamin B6 mg Potassium mg Folic acid2 μg Selenium μg Vitamin B12 μg Chromium μg Biotin μg Molybdenum μg Vitamin C mg Fluoride mg Chloride mg Phosphorus mg Boron mg Silicon mg 1 As amended by Regulation (EC) No. 1137/2008 (OJ L311, 21.11.2008, p.1; Regulation (EC) No. 1170/2009 (OJ L314, 1.12.2009, p.36); and Regulation (EC) No. 1161/2011 (OJ L296, 15.11.2011, p.29) 2 Folic acid is the term included in Annex I of Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labelling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions for nutrition labelling purposes and covers all forms of folates." Vitamins VITAMIN
    [Show full text]